Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bradley Theodore Hyman, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Bradley Hyman and Teresa Gomez-Isla.
Connection Strength

2.374
  1. Neuropathology of Alzheimer's disease. Handb Clin Neurol. 2008; 89:233-43.
    View in: PubMed
    Score: 0.371
  2. The natural history of Alzheimer neurofibrillary tangles and amyloid deposits. Neurobiol Aging. 1997 Jul-Aug; 18(4):386-7; discussion 389-92.
    View in: PubMed
    Score: 0.179
  3. Neuropathological markers of impaired cognition in the entorhinal cortex. Neurobiol Aging. 1996 Nov-Dec; 17(6):940-1; discussion 945-7.
    View in: PubMed
    Score: 0.171
  4. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol. 1996 Jan; 39(1):62-70.
    View in: PubMed
    Score: 0.161
  5. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging. 1994 May-Jun; 15(3):353-4; discussion 379-80.
    View in: PubMed
    Score: 0.144
  6. Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology. J Comp Neurol. 2013 Dec 15; 521(18):4236-48.
    View in: PubMed
    Score: 0.140
  7. Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. Neurobiol Aging. 2003 Mar-Apr; 24(2):245-58.
    View in: PubMed
    Score: 0.066
  8. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid. Brain Pathol. 2022 Mar; 32(2):e13035.
    View in: PubMed
    Score: 0.061
  9. Longitudinal Changes in Neuropsychiatric Symptoms: Impact of Discrepancy in Everyday Preferences Between Persons With Cognitive Impairment and Their Care Partners. Am J Geriatr Psychiatry. 2022 May; 30(5):619-623.
    View in: PubMed
    Score: 0.060
  10. Longitudinal differences in everyday preferences: Comparisons between people with cognitive impairment and their care partners. Int J Geriatr Psychiatry. 2021 Sep 08; 37(1).
    View in: PubMed
    Score: 0.060
  11. Predictors of the importance of everyday preferences for older adults with cognitive impairment. Int Psychogeriatr. 2022 Mar; 34(3):287-294.
    View in: PubMed
    Score: 0.057
  12. Description of microcolumnar ensembles in association cortex and their disruption in Alzheimer and Lewy body dementias. Proc Natl Acad Sci U S A. 2000 May 09; 97(10):5039-43.
    View in: PubMed
    Score: 0.055
  13. Abeta associated neuropil changes: correlation with neuronal loss and dementia. J Neuropathol Exp Neurol. 1998 Dec; 57(12):1122-30.
    View in: PubMed
    Score: 0.049
  14. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet. 1998 Nov; 7(12):1953-6.
    View in: PubMed
    Score: 0.049
  15. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease. Arch Neurol. 1998 Jul; 55(7):1001-4.
    View in: PubMed
    Score: 0.048
  16. Stereology: a practical primer for neuropathology. J Neuropathol Exp Neurol. 1998 Apr; 57(4):305-10.
    View in: PubMed
    Score: 0.047
  17. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol. 1998 Apr; 57(4):334-7.
    View in: PubMed
    Score: 0.047
  18. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. Arch Neurol. 1997 Oct; 54(10):1289-92.
    View in: PubMed
    Score: 0.046
  19. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease. JAMA Neurol. 2017 04 01; 74(4):427-436.
    View in: PubMed
    Score: 0.044
  20. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann N Y Acad Sci. 1996 Dec 16; 802:1-5.
    View in: PubMed
    Score: 0.043
  21. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly. Ann Neurol. 2016 12; 80(6):846-857.
    View in: PubMed
    Score: 0.043
  22. Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue. Sci Rep. 2016 09 15; 6:33079.
    View in: PubMed
    Score: 0.042
  23. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 1996 Aug; 47(2):444-8.
    View in: PubMed
    Score: 0.042
  24. Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly. Neurology. 2016 Aug 30; 87(9):920-6.
    View in: PubMed
    Score: 0.042
  25. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol. 1996 Jul; 40(1):55-66.
    View in: PubMed
    Score: 0.042
  26. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele. Neurology. 1996 Jul; 47(1):196-201.
    View in: PubMed
    Score: 0.042
  27. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Ann N Y Acad Sci. 1996 Jan 17; 777:158-65.
    View in: PubMed
    Score: 0.040
  28. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016 Jan; 79(1):110-9.
    View in: PubMed
    Score: 0.040
  29. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995 Aug; 38(2):254-9.
    View in: PubMed
    Score: 0.039
  30. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1642-51.
    View in: PubMed
    Score: 0.036
  31. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 2002 Apr 23; 58(8):1188-96.
    View in: PubMed
    Score: 0.016
  32. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000 Jul; 157(1):277-86.
    View in: PubMed
    Score: 0.014
  33. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 2000 Apr; 47(4):430-9.
    View in: PubMed
    Score: 0.014
  34. Risperidone treatment of behavioral disturbances in outpatients with dementia. J Neuropsychiatry Clin Neurosci. 1999; 11(3):336-42.
    View in: PubMed
    Score: 0.012
  35. Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease. J Alzheimers Dis. 1998 Dec; 1(2):119-134.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.